Top headlines: Farmers agree to talks; GST collections cross Rs 1 trn again

GST collections top Rs 1 trillion in November for second straight month, labs find lower Covid RT-PCR test pricing unviable, and more top headlines of the day

Farmers protest
Farmers stage a protest during Delhi Chalo agitation against Centre's new farm laws. Photo: PTI
BS Web Team New Delhi
2 min read Last Updated : Dec 01 2020 | 5:14 PM IST
Oyo has $1 billion fund until IPO

Ritesh Agarwal, founder and chief executive officer of Oyo Hotels, told employees the Indian startup is making progress in recovering from the coronavirus fallout and has about $1 billion to fund operations until an initial public offering. Read here

November GST collections top Rs 1 trn

Goods and services tax collections surpassed Rs one trillion for the second month straight in November. The mop up was Rs 192 crore less at Rs 1.049 trillion in November compared to Rs 1.051 trillion in October. This is the straight third month when the collections rose year-on-year. November collections were 1.42 per cent higher than the same month of the previous year. That way, the yearly growth came down from 10.25 per cent in October and 3.87 per cent in September. Read here

Factory activity falters

India’s manufacturing activity growth lost pace and fell to a three month low in November owing to slow expansion in factory orders and exports, according to a private survey. The IHS Markit India Manufacturing Purchasing Managers Index (PMI) fell from over a decade high of 58.9 in October to a three-month low of 56.3 in November, indicating a sustained recovery in the production sector despite some slowdown in momentum. Read here

Farmers unions, ministers begin talks

Government ministers and farmers on Tuesday evening began talks in Delhi as protests against new agricultural laws continued outside Delhi, media reports said. Read here

Labs find lower Covid RT-PCR test pricing unviable

While the move by state governments to cap the maximum price for Covid RT-PCR test might have made them more affordable for the public, the labs say it will not be a viable business and will lead to losses. In fact, smaller labs may opt out of Covid testing at lower prices, industry experts say. Read here



One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Coronavirustop news of the dayfarmer protests

Next Story